Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Walton, J R ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ALZHEIMER DISEASE VACCINE; DEFEROXAMINE; IRON REGULATORY PROTEIN 2;

AGE; ALUMINUM CHELATION; ALUMINUM OVERLOAD; ALZHEIMER DISEASE; AMYLOID PLAQUE; BIOACCUMULATION; BRAIN CELL; BRAIN DEVELOPMENT; BRAIN LEVEL; BRAIN REGION; CELL SHAPE; CHRONIC ALUMINUM NEUROTOXICITY; CHRONIC DISEASE; DENDRITE; DIET SUPPLEMENTATION; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOWN SYNDROME; ENTORHINAL CORTEX; EXPOSURE; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; IRON CHELATION; MENTAL DETERIORATION; MICROTUBULE; NERVE FIBER; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 84866245593     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/914947     Document Type: Review

References (150)

1. Price M., Jackson J.,. Alzheimer's Disease International World Alzheimer Report 2009
2. Morris J. C., Differential diagnosis of Alzheimer's disease. Clinics in Geriatric Medicine 1994 10 2 257 276 2-s2.0-0028362482
3. Humphry G. M., Old Age: The Results of Information Received Respecting Nearly Nine Hundred Persons Who Had Attained the Age of Eighty Years, Including Seventy-Four Centenarians 1889 Cambridge, UK MacMillan and Bowes
4. Henderson A. S., The epidemiology of Alzheimer's disease. British Medical Bulletin 1986 42 1 3 10 2-s2.0-0022636502
5. Blansjaar B. A., Thomassen R., Van Schaick H. W., Prevalence of dementia in centenarians. International Journal of Geriatric Psychiatry 2000 15 3 219 225
6. Alzheimer A., Ueber eine eigenartige Erkrankung der Hirnrinde. Zentralblatt fur Nevenheilkunde Psychiatrie 1907 30 177 179
7. Walton J. R., A longitudinal study of rats chronically exposed to aluminum at human dietary levels. Neuroscience Letters 2007 412 1 29 33 2-s2.0-33845938544 10.1016/j.neulet.2006.08.093
8. Walton J. R., Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents. NeuroToxicology 2009 30 2 182 193 2-s2.0-61849138379 10.1016/j.neuro.2008.11.012
9. Hinds J. W., McNelly N. A., Aging of the rat olfactory bulb: growth and atrophy of constituent layers and changes in size and number of mitral cells. Journal of Comparative Neurology 1977 171 3 345 367 2-s2.0-0017350573
10. Walton J. R., The role of limited cell replicative capacity in pathological age change. A review. Mechanisms of Ageing and Development 1982 19 3 217 244 2-s2.0-0020323136 10.1016/0047-6374(82)90056-2
11. Loesche O., Steward J., Behavioral correlates of denervation and reinnervation of the hippocampal formation of the rat: recovery of alternation performance following unilateral entorhinal cortical lesions. Brain Research Bulletin 1977 2 1 31 39
12. Steward O., Loesche J., Horton W. C., Behavioral correlates of denervation and reinnervation of the hippocampal formation of the rat: open field activity and cue utilization following bilateral entorhinal cortex lesions. Brain Research Bulletin 1977 2 1 41 48 2-s2.0-0017362412 10.1016/0361-9230(77)90023-5
13. Greger J. L., Aluminum metabolism. Annual Review of Nutrition 1993 13 43 63 2-s2.0-0027303757
14. Everitt A. V., Ageing rat colonies at the University of Sydney. Proceedings of the Australian Association for Gerontology 1991 26 79 82
15. McLachlan D. R., Aluminium and the risk for Alzheimer's disease. Environmetrics 1995 6 3 233 275
16. Markesbery W. R., Ehmann W. D., Hossain T. I. M., Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging. Annals of Neurology 1981 10 6 511 516 2-s2.0-0019865489
17. McDermott J. R., Smith A. I., Iqbal K., Wisniewski H. M., Brain aluminium in aging and Alzheimer disease. Neurology 1979 29 6 809 814 2-s2.0-0018333867
18. Shimizu H., Mori T., Koama M., Sekiya M., Ooami H., A correlative study of the aluminum content and aging changes of the brain in non-demented elderly subjects. Nippon Ronen Igakkai Zasshi 1994 31 12 950 960
19. Edwardson J. A., Moore P. B., Ferrier I. N., Lilley J. S., Newton G. W. A., Barker J., Templar J., Day J. P., Effect of silicon on gastrointestinal absorption of aluminium. The Lancet 1993 342 8865 211 212 2-s2.0-0027194458 10.1016/0140-6736(93)92301-9
20. World Health Organization,. 'Aluminium' in: 657. Aluminium (WHO Food Additive Series 24), 1989
21. Walton J. R., Evidence that total dietary aluminum ingestion is a major risk factor for Alzheimer's disease. Current Inorganic Chemistry 2012 2 19 39
22. Walton J., Tuniz C., Fink D., Jacobsen G., Wilcox D., Uptake of trace amounts of aluminum into the brain from drinking water. NeuroToxicology 1995 16 1 187 190 2-s2.0-0028962608
23. Drüeke T. B., Jouhanneau P., Banide H., Lacour B., Yiou F., Raisbeck G., Effects of silicon, citrate and the fasting state on the intestinal absorption of aluminium in rats. Clinical Science 1997 92 1 63 67 2-s2.0-0031018838
24. Zafar T. A., Weaver C. M., Martin B. R., Flarend R., Elmore D., Aluminum (26Al) Metabolism in Rats. Experimental Biology and Medicine 1997 216 1 81 85 2-s2.0-0031255178
25. World Health Organization, Evaluation of certain food additives and contaminants in Sixty-seventh report of the joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series 2007.
26. Tomljenovic L., Shaw C. A., Aluminum vaccine adjuvants: are they safe? Current Medicinal Chemistry 2011 18 17 2630 2637 2-s2.0-79957951065 10.2174/092986711795933740
27. Redhead K., Quinlan G. J., Das R. G., Gutteridge J. M. C., Aluminium-adjuvanted vaccines transiently increase aluminium levels in murine brain tissue. Pharmacology and Toxicology 1992 70 4 278 280 2-s2.0-0026508507
28. Anane R., Bonini M., Grafeille J. M., Creppy E. E., Bioaccumulation of water soluble aluminium chloride in the hippocampus after transdermal uptake in mice. Archives of Toxicology 1995 69 8 568 571 2-s2.0-0029121166 10.1007/s002040050214
29. Lione A., Aluminum toxicology and the aluminum-containing medications. Pharmacology and Therapeutics 1985 29 2 255 285 2-s2.0-0022399283
30. Walton J. R., Aluminum in hippocampal neurons from humans with Alzheimer's disease. NeuroToxicology 2006 27 3 385 394 2-s2.0-33646180185 10.1016/j.neuro.2005.11.007
31. Walton J. R., Brain lesions comprised of aluminum-rich cells that lack microtubules may be associated with the cognitive deficit of Alzheimer's disease. NeuroToxicology 2009 30 6 1059 1069 2-s2.0-71049182361 10.1016/j.neuro.2009.06.010
32. McLachlan D. R. C., Dalton A. J., Kruck T. P. A., Bell M. Y., Smith W. L., Kalow W., Andrews D. F., Intramuscular desferrioxamine in patients with Alzheimer's disease. The Lancet 1991 337 8753 1304 1308 2-s2.0-0025726462 10.1016/0140-6736(91)92978-B
33. McLachlan D. R. C., Smith W. L., Kruck T. P., Desferrioxamine and Alzheimer's disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring 1993 15 6 602 607 2-s2.0-0027515763
34. Walton J. R., A bright field/fluorescent stain for aluminum: its specificity, validation, and staining characteristics. Biotechnic and Histochemistry 2004 79 5-6 169 176 2-s2.0-12144266850 10.1080/10520290400015423
35. Kowall N. W., Pendlebury W. W., Kessler J. B., Perl D. P., Beal M. F., Aluminum-induced neurofibrillary degeneration affects a subset of neurons in rabbit cerebral cortex, basal forebrain and upper brainstem. Neuroscience 1989 29 2 329 337 2-s2.0-0024559677
36. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991 82 4 239 259 2-s2.0-0025863618
37. Kovács T., Cairns N. J., Lantos P. L., Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. NeuroReport 2001 12 2 285 288 2-s2.0-0035847617
38. Arnold S. E., Hyman B. T., Flory J., Damasio A. R., Van Hoesen G. W., The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1991 1 1 103 116 2-s2.0-0025717816
39. Walton J. R., An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. Journal of Inorganic Biochemistry 2007 101 9 1275 1284 2-s2.0-34548190489 10.1016/j.jinorgbio.2007.06.001
40. Walton J. R., Wang M. X., APP expression, distribution and accumulation are altered by aluminum in a rodent model for Alzheimer's disease. Journal of Inorganic Biochemistry 2009 103 11 1548 1554 2-s2.0-70350033993 10.1016/j.jinorgbio.2009.07.027
41. Baas P. W., Microtubule transport in the axon. International Review of Cytology 2002 212 41 62 2-s2.0-0036140644 10.1016/S0074-7696(01)12003-6
42. Gray E. G., Paula-Barbosa M., Roher A., Alzheimer's disease: paired helical filaments and cytomembranes. Neuropathology and Applied Neurobiology 1987 13 2 91 110 2-s2.0-0023187131
43. Hempen B., Brion J. P., Reduction of acetylated α -tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 1996 55 9 964 972 2-s2.0-0030240325
44. Hatanpää K., Brady D. R., Stoll J., Rapoport S. I., Chandrasekaran K., Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Annals of Neurology 1996 40 3 411 420 2-s2.0-0029811758
45. Scheibel M. E., Lindsay R. D., Tomiyasu U., Scheibel A. B., Progressive dendritic changes in the aging human limbic system. Experimental Neurology 1976 53 2 420 430 2-s2.0-0017173036
46. Petit T. L., Biederman G. B., McCullen P. A., Neurofibrillary degeneration, dendritic dying back, and learning-memory deficits after aluminum administration: implications for brain aging. Experimental Neurology 1980 67 1 152 162 2-s2.0-0018903535
47. Uemura E., Ireland W. P., Dendritic alterations in chronic animals with experimental neurofibrillary changes. Experimental Neurology 1985 89 3 530 542 2-s2.0-0022263309
48. Flood D. G., Coleman P. D., Failed compensatory dendritic growth as a pathophysiological process in Alzheimer's disease. Canadian Journal of Neurological Sciences 1986 13 4 475 479 2-s2.0-0022973690
49. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., Katzman R., Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology 1991 30 4 572 580 2-s2.0-0025987048 10.1002/ana.410300410
50. Andrasi E., Pali N., Molnar Z., Kosel S., Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients. Journal of Alzheimer's Disease 2005 7 4 273 284
51. Crapper D. R., Krishnan S. S., Quittkat S., Aluminium, neurofibrillary degeneration and Alzheimer's disease. Brain 1976 99 1 67 80 2-s2.0-0017260845
52. Krishnan S. S., McLachlan D. R., Krishnan B., Fenton S. S. A., Harrison J. E., Aluminum toxicity to the brain. Science of the Total Environment 1988 71 1 59 64 2-s2.0-0023833942
53. Trapp G. A., Miner G. D., Zimmerman R. L., Aluminum levels in brain in Alzheimer's disease. Biological Psychiatry 1978 13 6 709 718 2-s2.0-0018169542
54. Xu N., Majidi V., Markesbery W. R., Ehmann W. D., Brain aluminum in Alzheimer's disease using an improved GFAAS method. NeuroToxicology 1992 13 4 735 744 2-s2.0-0027082739
55. Van Hoesen G. W., Pandya D. N., Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. III. Efferent connections. Brain Research 1975 95 1 39 59 2-s2.0-0016829574 10.1016/0006-8993(75)90206-1
56. Van Hoesen G. W., Hyman B. T., Damasio A. R., Entorhinal cortex pathology in Alzheimer's disease. Hippocampus 1991 1 1 1 8 2-s2.0-0025717403
57. Bayer S. A., Paxinos G., Hippocampal region. The Rat Central Nervous System 1985 1st San Diego, Calif, USA Academic Press 335 352
58. Insausti R., Comparative anatomy of the entorhinal cortex and hippocampus in mammals. Hippocampus 1993 3 19 26 2-s2.0-0027522154
59. Germroth P., Schwerdtfeger W. K., Buhl E. H., Ultrastructure and aspects of functional organization of pyramidal and nonpyramidal entorhinal projection neurons contributing to the perforant path. Journal of Comparative Neurology 1991 305 2 215 231 2-s2.0-0026096628
60. Beall M. J., Lewis D. A., Heterogeneity of layer II neurons in human entorhinal cortex. Journal of Comparative Neurology 1992 321 2 241 266 2-s2.0-0026650060 10.1002/cne.903210206
61. Mikkonen M., Pitkänen A., Soininen H., Alafuzoff I., Miettinen R., Morphology of spiny neurons in the human entorhinal cortex: intracellular filling with Lucifer Yellow. Neuroscience 2000 96 3 515 522 2-s2.0-0342905150 10.1016/S0306-4522(99)00592-8
62. Klink A., Alonso R., Morphological characteristics of layer II projection neurons in the rat medial entorhinal cortex. Hippocampus 1997 7 5 571 583
63. Hyman B. T., Van Hoesen G. W., Kromer L. J., Damasio A. R., Perforant pathway changes and the memory impairment of Alzheimer's disease. Annals of Neurology 1986 20 4 472 481 2-s2.0-0022535539
64. Beckstead R. M., Afferent connections of the entorhinal area in the rat as demonstrated by retrograde cell-labeling with horseradish peroxidase. Brain Research 1978 152 2 249 264 2-s2.0-0018220836 10.1016/0006-8993(78)90254-8
65. Flood D. G., Buell S. J., Defiore C. H., Horwitz G. J., Coleman P. D., Agerelated dendritic growth in dentate gyrus of human brain is followed by regression in the 'oldest old' Brain Research 1985 345 2 366 368
66. Grandes P., Streit P., Effect of perforant path lesion on pattern of glutamate-like immunoreactivity in rat dentate gyrus. Neuroscience 1991 41 2-3 391 400 2-s2.0-0025761428 10.1016/0306-4522(91)90335-L
67. Skelton R. W., Modelling recovery of cognitive function after traumatic brain injury: spatial navigation in the Morris water maze after complete or partial transections of the perforant path in rats. Behavioural Brain Research 1998 96 1-2 13 35 2-s2.0-0032211343 10.1016/S0166-4328(97)00199-X
68. Geddes J. W., Monaghan D. T., Cotman C. W., Plasticity of hippocampal circuitry in Alzheimer's disease. Science 1985 230 4730 1179 1181 2-s2.0-0022397573
69. Van Hoesen G. W., The primate parahippocampal gyrus: new insights regarding its cortical connections. Trends in Neurosciences 1982 5 345 350
70. Scoville W. B., Milner B., Loss of recent memory after bilateral hippocampal lesions. Journal of Neurology, Neurosurgery, and Psychiatry 1957 20 1 11 21 2-s2.0-0010529277
71. Damasio A. R., Eslinger P. J., Damasio H., Van Hoesen G. W., Cornell S., Multi-modal amnesic syndrome following bilateral temporal and basal forebrain damage: the case of patient DRB. Archives of Neurology 1985 42 3 252 259
72. Walton J. R., Evidence for participation of aluminum in neurofibrillary tangle formation and growth in Alzheimer's disease. Journal of Alzheimer's Disease 2010 22 1 65 72 2-s2.0-78650643641 10.3233/JAD-2010-100486
73. Wisniewski H. M., Merz G. S., Katzman R., Neuritic and amyloid plaques in senile dementia of the Alzheimer type. Banbury Report 15: Biological Aspects of Alzheimer's Disease 1983 New York, NY, USA Cold Spring Harbor 145 155
74. Salat D. H., Tuch D. S., van der Kouwe A. J. W., Greve D. N., Pappu V., Lee S. Y., Hevelone N. D., Zaleta A. K., Growdon J. H., Corkin S., Fischl B., Rosas H. D., White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiology of Aging 2010 31 2 244 256 2-s2.0-71349083023 10.1016/j.neurobiolaging.2008.03.013
75. Augustinack J. C., Helmer K., Huber K. E., Kakunoori S., Zöllei L., Fischl B., Direct visualization of the perforant pathway in the human brain with ex vivo diffusion tensor imaging. Frontiers in Human Neuroscience 2010 4 2-s2.0-79953018186 10.3389/fnhum.2010.00042
76. Hyman B. T., Van Hoesen G. W., Damasio A. R., Barnes C. L., Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984 225 4667 1168 1170 2-s2.0-0021145680
77. Pearson R. C. A., Esiri M. M., Hiorns R. W., Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1985 82 13 4531 4534 2-s2.0-0345512210
78. Armstrong R. A., Is the clustering of neurofibrillary tangles in Alzheimer's patients related to the cells of origin of specific cortico-cortical projections? Neuroscience Letters 1993 160 1 57 60 2-s2.0-0027375655 10.1016/0304-3940(93)90916-9
79. Esiri M. M., Chance S. A., Vulnerability to Alzheimer's pathology in neocortex: the roles of plasticity and columnar organization. Journal of Alzheimer's Disease 2006 9 3 79 89 2-s2.0-33747447701
80. Yates P. O., Mann D. M. A., Kellett J. M., Aluminosilicates and Alzheimer's disease. The Lancet 1986 1 8482 681 682 2-s2.0-0022574612
81. Van Rhijn A., Corrigan F. M., Ward N. I., Serum aluminum in senile dementia of Alzheimer's type and in multi-infarct dementia. Trace Elements in Medicine 1989 6 1 24 26 2-s2.0-0024508643
82. Corrigan F. M., Crichton J. S., Van Rhijn A. G., Skinner E. R., Ward N. I., Transferrin, cholesterol and aluminium in Alzheimer's disease. Clinica Chimica Acta 1992 211 1-2 121 123
83. Naylor G. J., Smith A. H. W., McHarg A., Walker P. J., Shepherd B., Ward N. I., Harper M., Raised serum aluminum concentration in Alzheimer's disease. Trace Elements in Medicine 1989 6 3 93 95 2-s2.0-0024468345
84. Zapatero M. D., De Jalon A. G., Pascual F., Calvo M. L., Escanero J., Marro A., Serum aluminum levels in Alzheimer's disease and other senile dementias. Biological Trace Element Research 1995 47 1-3 235 240 2-s2.0-0028908901
85. Roberts N. B., Clough A., Bellia J. P., Kim J. Y., Increased absorption of aluminium from a normal dietary intake in dementia. Journal of Inorganic Biochemistry 1998 69 3 171 176 2-s2.0-0031838343 10.1016/S0162-0134(97)10015-0
86. Shore D., Millson M., Holtz J. L., King S. W., Bridge T. P., Wyatt R. J., Serum aluminum in primary degenerative dementia. Biological Psychiatry 1980 15 6 971 977
87. Moore P. B., Day J. P., Taylor G. A., Ferrier I. N., Fifield L. K., Edwardson J. A., Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry. Dementia and Geriatric Cognitive Disorders 2000 11 2 66 69 2-s2.0-0033998274
88. Moore P. B., Edwardson J. A., Ferrier I. N., Taylor G. A., Lett D., Tyrer S. P., Day J. P., King S. J., Lilley J. S., Gastrointestinal absorption of aluminum is increased in Down's syndrome. Biological Psychiatry 1997 41 4 488 492 2-s2.0-0031568909 10.1016/S0006-3223(96)00045-5
89. Mann D. M. A., Prasher V. P., Neuropathology of Alzheimer's disease in Down syndrome. Down Syndrome and Alzheimer's Disease 2006 Milton Keynes, UK Radcliffe Publishing 15 36
90. Ropper A. H., Williams R. S., Relationship between plaques, tangles, and dementia in Down syndrome. Neurology 1980 30 6 639 644 2-s2.0-0018852777
91. Alfrey A. C., LeGendre G. R., Kaehny D., The dialysis encephalopathy syndrome. Possible aluminium intoxication. New England Journal of Medicine 1976 294 4 184 188 2-s2.0-0017234506
92. Ackrill P., Day J. P., The use of desferrioximine in dialysis-associated aluminium disease. Contributions to Nephrology 1993 102 125 134 2-s2.0-0027356274
93. Kobayashi S., Hirota N., Saito K., Utsuyama M., Aluminum accumulation in tangle-bearing neurons of Alzheimer's disease with Balint's syndrome in a long-term aluminum refiner. Acta Neuropathologica 1987 74 1 47 52 2-s2.0-0023190136
94. Yasui M., Yase Y., Ota K., Garruto R. M., Aluminum deposition in the central nervous system of patients with amyotrophic lateral sclerosis from the Kii Peninsula of Japan. NeuroToxicology 1991 12 3 615 620 2-s2.0-0025949960
95. Rifat S. L., Eastwood M. R., Mclachlan D. R. C., Corey P. N., Effect of exposure of miners to aluminium powder. The Lancet 1990 336 8724 1162 1165 2-s2.0-0025130026
96. Simchowicz T., La maladie d'Alzheimer et son rapport avec la démence sénile. L'Encéphale 1914 218 231
97. Hirano A., Kurland L. T., Krooth R. S., Lessell S., Parkinsonism-dementia complex, an endemic disease on the island of guam: I. Clinical features. Brain 1961 84 4 642 661 2-s2.0-73049132762 10.1093/brain/84.4.642
98. Crapper D. R., Krishnan S. S., Dalton A. J., Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 1973 180 4085 511 513 2-s2.0-0015913994
99. Yamamoto H., Saitoh Y., Yasugawa S., Miyamoto E., Dephosphorylation of tau factor by protein phosphatase 2A in synaptosomal cytosol fractions, and inhibition by aluminum. Journal of Neurochemistry 1990 55 2 683 690
100. Amador F. C., Henriques A. G., Da Cruz E Silva O. A. B., Da Cruz E Silva E. F., Monitoring protein phosphatase 1 isoform levels as a marker for cellular stress. Neurotoxicology and Teratology 2004 26 3 387 395 2-s2.0-2042447806 10.1016/j.ntt.2003.12.007
101. 2+ modulatory action on GABA transport in brain cortex nerve terminals. Journal of Inorganic Biochemistry 2003 97 1 132 142 2-s2.0-0141516668 10.1016/S0162-0134(03)00256-3
102. Goedert M., Jakes R., Qi Z., Wang J. H., Cohen P., Protein phosphatase 2A is the major enzyme in brain that dephosphorylates τ protein phosphorylated by prolinedirected protein kinases or cyclic AMP-dependent protein kinase. Journal of Neurochemistry 1995 65 6 2804 2807
103. Gong C. X., Shaikh S., Wang J. Z., Zaidi T., Grundke-Iqbal I., Iqbal K., Phosphatase activity toward abnormally phosphorylated τ: decrease in Alzheimer disease brain. Journal of Neurochemistry 1995 65 2 732 738 2-s2.0-0029113874
104. Shin R.-W., Iwaki T., Kitamoto T., Sato Y., Tateishi J., Massive accumulation of modified tau and severe depletion of normal tau characterize the cerebral cortex and white matter of Alzheimer's disease. American Journal of Pathology 1992 140 4 937 945
105. Harrington C. R., Wischik C. M., McArthur F. K., Taylor G. A., Edwardson J. M., Candy J. A., Alzheimer's disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal diaysis patients. The Lancet 1994 343 8904 993 997
106. Levy R., Shohat L., Solomon B., Specificity of an anti-aluminium monoclonal antibody toward free and protein-bound aluminium. Journal of Inorganic Biochemistry 1998 69 3 159 163 2-s2.0-0031863739 10.1016/S0162- 0134(97)10013-7
107. Solomon B., Koppel R., Jossiphov J., Immunostaining of calmodulin and aluminium in Alzheimer's disease-affected brains. Brain Research Bulletin 2001 55 2 253 256 2-s2.0-0035872459 10.1016/S0361-9230(01)00466-X
108. Perl D. P., Brody A. R., Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 1980 208 4441 297 299 2-s2.0-0018827099
109. Good P. F., Perl D. P., Bierer L. M., Schmeidler J., Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe [LAMMA] study. Annals of Neurology 1992 31 286 292
110. Perl P. F., Good D. P., The association of aluminium, Alzheimer's disease and neurofibrillary tangles. Journal of Neural Transmission 1987 24 205 211
111. Head E., Moffat K., Das P., Sarsoza F., Poon W. W., Landsberg G., Cotman C. W., Murphy M. P., β -Amyloid deposition and tau phosphorylation in clinically characterized aged cats. Neurobiology of Aging 2005 26 5 749 763 2-s2.0-13644253798 10.1016/j.neurobiolaging.2004.06.015
112. Crapper D. R., Dalton A. J., Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention. Physiology and Behavior 1973 10 5 935 945 2-s2.0-0015889062 10.1016/0031-9384(73)90064-4
113. King G. A., DeBoni U., Crapper D. R., Effect of aluminum upon conditioned avoidance response acquisition in the absence of neurofibrillary degeneration. Pharmacology, Biochemistry and Behavior 1975 3 6 1003 1009
114. Savory J., Huang Y., Herman M. M., Reyes M. R., Wills M. R., Tau immunoreactivity associated with aluminum maltolate-induced neurofibrillary degeneration in rabbits. Brain Research 1995 669 2 325 329
115. Huang Y., Herman M. M., Liu J., Katsetos C. D., Wills M. R., Savory J., Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A β α 1-antichymotrypsin and ubiquitin-protein conjugates. Brain Research 1997 771 2 213 220 2-s2.0-0030815354 10.1016/S0006-8993(97)00780-4
116. Ruben G. C., Wang J. Z., Iqbal K., Grundke-Iqbal I., Paired helical filaments (PHFs) are a family of single filament structures with a common helical turn period: negatively stained PHF imaged by TEM and measured before and after sonication, deglycosylation, and dephosphorylation. Microscopy Research and Technique 2005 67 3-4 175 195 2-s2.0-24144499309 10.1002/jemt.20197
117. Wischik C. M., Crowther R. A., Stewart M., Roth M., Subunit structure of paired helical filaments in Alzheimer's disease. Journal of Cell Biology 1985 100 6 1905 1912 2-s2.0-0021796959
118. Lukiw W. J., Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochemical Research 2004 29 6 1287 1297 2-s2.0-3142718813 10.1023/B:NERE.0000023615.89699.63
119. Alexandrov P. N., Zhao Y., Pogue A. I., Tarr M. A., Kruck T. P. A., Percy M. E., Cui J. G., Lukiw W. J., Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells. Journal of Alzheimer's Disease 2005 8 2 117 127 2-s2.0-32444445371
120. Shigematsu P. L., McGeer K., Accumulation of amyloid precursor protein in damaged neuronal processes and microglia following intracerebral administration of aluminium salts. Brain Research 1992 593 1 117 123
121. Exley C., Price N. C., Kelly S. M., Birchall J. D., An interaction of β -amyloid with aluminium in vitro. FEBS Letters 1993 324 3 293 295 2-s2.0-0027198687 10.1016/0014-5793(93)80137-J
122. Kawahara M., Muramoto K., Kobayashi K., Mori H., Kuroda Y., Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro. Biochemical and Biophysical Research Communications 1994 198 2 531 535
123. Kawahara M., Kato M., Kuroda Y Y., Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Research Bulletin 2001 55 2 211 217
124. 42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. Journal of Alzheimer's Disease 2004 6 3 291 301
125. Banks W. A., Niehoff M. L., Drago D., Zatta P., Aluminum complexing enhances amyloid β protein penetration of blood-brain barrier. Brain Research 2006 1116 1 215 221 2-s2.0-33749425248 10.1016/j.brainres.2006.07.112
126. Rodella L. F., Ricci F., Borsani E., Stacchiotti A., Foglio E., Favero G., Rezzani R., Mariani C., Bianchi R., Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain. Histology and Histopathology 2008 23 4-6 433 439 2-s2.0-42349086174
127. Drago D., Bolognin S., Zatta P., Role of metal ions in the abeta oligomerization in Alzheimer's disease and in other neurological disorders. Current Alzheimer Research 2008 5 6 500 507
128. Walton J. R., Aluminum disruption of calcium homeostasis and signal transduction resembles change that occurs in aging and Alzheimer's disease. Journal of Alzheimer's Disease 2012 29 2 255 273
129. Pratico D., Uryu K., Sung S., Tang S., Trojanowski J. Q., -Y Lee V. M., Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB Journal 2002 16 9 1138 1141
130. Sato N., Hori O., Yamaguchi A., Lambert J. -C., Chartier-Harlin M. -C., Robinson P. A., Delacourte A., Schmidt A. M., Furuyama T., Imaiziumi K., Tohyama M., Takagi T., A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue. Journal of Neurochemistry 1999 72 6 2498 2505
131. Sato N., Imaizumi K., Manabe T., Taniguchi M., Hitomi J., Katayama T., Yoneda T., Morihara T., Yasuda Y., Takagi T T., Kudo, Tsuda T., Itoyama Y., Makifuchi T., Fraser P. E., St George-Hyslop P., Tohyama M., Increased production of β -amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2. Journal of Biological Chemistry 2001 276 2108 2114
132. Matsuzaki S., Manabe T., Katayama T., Nishikawa A., Yanagita T., Okuda H., Yasuda Y., Miyata S., Meshitsuka S., Tohyama M., Metals accelerate production of the aberrant splicing isoform of the presenilin-2. Journal of Neurochemistry 2004 88 6 1345 1351 2-s2.0-12144288051
133. Sun X., Liu Z., Zhang X., Zhang Z., Effects of aluminum on the number of neurons [sic] granulovacuolar degeneration in rats Journal of Hygiene Research 1999 28 164 166
134. Miu A. C., Andreescu C. E., Vasiu R., Olteanu A. I., A behavioral and histological study of the effects of long-term exposure of adult rats to aluminum. International Journal of Neuroscience 2003 113 9 1197 1211 2-s2.0-0043189128 10.1080/00207450390232292
135. Deibel M. A., Ehmann W. D., Markesbery W. R., Copper, iron and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. Journal of Neurological Sciences 1996 143 1-2 137 142
136. Smith M. A., Wehr K., Harris P. L. R., Siedlak S. L., Connor J. R., Perry G., Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Research 1998 788 1-2 232 236 2-s2.0-0032579795 10.1016/S0006-8993(98) 00002-X
137. Martin R. B., The chemistry of aluminum as related to biology and medicine. Clinical Chemistry 1986 32 10 1797 1806 2-s2.0-0022870880
138. Day J. P., Barker J., Evans L. J. A., Perks J., Seabright P. J., Ackrill P., Lilley J. S., Drumm P. V., Newton G. W. A., Aluminium absorption studied by 26Al tracer. The Lancet 1991 337 8753 1345 2-s2.0-0025857464
139. Trapp G. A., Plasma aluminum is bound to transferrin. Life Sciences 1983 33 4 311 316 2-s2.0-0020536622 10.1016/0024-3205(83)90505-2
140. Jeffries W. A., Brandon M. R., Hunt S. V., Williams A. F., Gatter K. C., Mason D. Y., Transferrin receptors on endothelium of brain capillaries. Nature 1984 312 162 163 10.1038/312162a0
141. Roskams A. J., Connor J. R., Aluminum access to the brain: a role for transferrin and its receptor. Proceedings of the National Academy of Sciences of the United States of America 1990 87 22 9024 9027 2-s2.0-0025221851 10.1073/pnas.87.22.9024
142. Oshiro S., Kawahara M., Mika S., Muramoto K., Kobayashi K., Ishige R., Nozawa K., Hori M., Yung C., Kitajima S., Kuroda Y., Aluminum taken up by transferrin-independent iron uptake affects the iron metabolism in rat cortical cells. Journal of Biochemistry 1998 123 1 42 46
143. Yamanaka K., Minato N., Iwai K., Stabilization of iron regulatory protein 2, IRP2, by aluminum. FEBS Letters 1999 462 1-2 216 220 2-s2.0-0032735145 10.1016/S0014-5793(99)01533-1
144. Abreo K., Abreo F., Sella M. L., Jain S., Aluminum enhances iron uptake and expression of neurofibrillary tangle protein in neuroblastoma cells. Journal of Neurochemistry 1999 72 5 2059 2064
145. Ward R. M., Zhang Y., Crichton R. R., Aluminum toxicity and iron homeostasis. Journal of Inorganic Biochemistry 2001 87 1-2 9 14
146. Beal M. F., Mazurek M. F., Ellison D. W., Kowall N. W., Solomon P. R., Pendlebury W. W., Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits. Neuroscience 1989 29 2 339 346
147. Julka D., Sandhir R., Gill K. D., Altered cholinergic metabolism in rat CHS following aluminum exposure: implications on learning performance. Journal of Neurochemistry 1995 65 2157 2164
148. Ganrot P. O., Metabolism and possible health effects of aluminium. Environmental Health Perspectives 1986 65 363 441
149. Morris C. M., Candy J. M., Oakley A. E., Taylor G. A., Mountfort S., Bishop H., Ward M. K., Bloxham C. A., Edwardson J. A., Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients. Journal of the Neurological Sciences 1989 94 1-3 295 306 2-s2.0-0024802555 10.1016/0022-510X(89)90238-4
150. Edwardson J. A., Ferrier I., McArthur F. K., McArthur M. K., McKeith I. G., McLaughlin I., Morris C. M., Mountfort S. A., Oakley A. E., Taylor G. A., Ward J. M., Candy M. K., Nicolini M., Zatta P. F., Corain B., Alzheimer's disease and the aluminium hypothesis. Aluminum in Chemistry Biology and Medicine. A Series of Advances 1991 1 New York, NY, USA Raven Press 85 96